C Chittasupho, S Tadtong, S Vorarat, W Imaram… - Pharmaceutics, 2022 - mdpi.com
The first line therapy of patients with Parkinson's disease, a neurodegenerative disorder
caused by the degeneration of dopaminergic neurons, is levodopa (L-dopa) given orally …